Compounds > trimethylamine
Page last updated: 2024-10-20

trimethylamine and Bone Loss, Osteoclastic

trimethylamine has been researched along with Bone Loss, Osteoclastic in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Trimethylamine-N-oxide (TMAO), an important gut microbiota (GM)-derived metabolite, has been shown to be abnormally increased in osteoporosis."4.12Trimethylamine-N-Oxide Promotes Osteoclast Differentiation and Bone Loss via Activating ROS-Dependent NF-κB Signaling Pathway. ( Fu, L; Hao, Y; Wang, N, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, N1
Hao, Y1
Fu, L1

Other Studies

1 other study available for trimethylamine and Bone Loss, Osteoclastic

ArticleYear
Trimethylamine-N-Oxide Promotes Osteoclast Differentiation and Bone Loss via Activating ROS-Dependent NF-κB Signaling Pathway.
    Nutrients, 2022, Sep-23, Volume: 14, Issue:19

    Topics: Acetylcysteine; Actins; Animals; Bone Resorption; Cattle; Cell Differentiation; Methylamines; Mice;

2022